Kabami Jane, Turyakira Eleanor, Biraro Sam, Bajunirwe Francis
Department of Community Health, Mbarara University of Science and Technology, P,O, BOX 1410, Mbarara, Uganda.
Reprod Health. 2014 Dec 6;11:81. doi: 10.1186/1742-4755-11-81.
Antiretroviral treatment restores physical functioning and may have an impact on fertility desires. Counseling is given to HIV positive women to create awareness and to provide information on pregnancy and delivery. The purpose of this study was to determine the incidence of pregnancy and factors that predict pregnancy among women of reproductive age receiving HIV care and treatment at a large urban center in western Uganda.
We conducted a retrospective cohort study using routinely collected data at the Immune Suppression (ISS) Clinic of Mbarara Regional Referral Hospital located in Mbarara District, western Uganda collected between January 2006 and June 2010. Women aged 15 to 50 years were eligible for analysis. The primary outcome was incidence of pregnancy calculated as number of pregnancies per 1000 person years (PY). Data was analyzed by calendar year and year of enrolment and used survival analysis to determine the predictors of pregnancy.
A total of 3144 women were included with a median follow up of 12.5 months. The overall incidence rate was 90.7 pregnancies per 1000 person years. Incidence increased from 29.8 pregnancies per 1000 PY in 2006 to 122 pregnancies per 1000 PY in 2010 (p < 0.001). Significant predictors for pregnancy were younger age (HR 10.96 95% CI 3.22-37.2), married (HR 2.09 95% CI 1.69-2.64) and single (HR 1.95 95% CI 1.34-2.84) compared to widowed or separated, primary education (HR 1.65 95% CI 1.02-2.66), not knowing the HIV status of the spouse (HR 1.46, 95%CI 1.13-1.93) compared to knowing. The use of family planning (HR 0.23 95% CI 0.18- 0.30) and an increase in CD4 count between baseline and most recent count were protective against pregnancy. ART use was not a significant predictor.
Incidence of pregnancy among women receiving routine HIV care and treatment has increased and is almost comparable to that in the general population. Thus routine HIV care should integrate reproductive health needs for these women.
抗逆转录病毒治疗可恢复身体机能,并可能对生育意愿产生影响。会为感染艾滋病毒的女性提供咨询,以提高认识并提供有关怀孕和分娩的信息。本研究的目的是确定在乌干达西部一个大型城市中心接受艾滋病毒护理和治疗的育龄妇女的怀孕发生率以及预测怀孕的因素。
我们进行了一项回顾性队列研究,使用位于乌干达西部姆巴拉拉区的姆巴拉拉地区转诊医院免疫抑制(ISS)诊所2006年1月至2010年6月期间常规收集的数据。年龄在15至50岁之间的女性符合分析条件。主要结局是怀孕发生率,以每1000人年(PY)的怀孕次数计算。数据按日历年和入组年份进行分析,并使用生存分析来确定怀孕的预测因素。
共纳入3144名女性,中位随访时间为12.5个月。总体发生率为每1000人年90.7次怀孕。发生率从2006年的每1000 PY 29.8次怀孕增加到2010年的每1000 PY 122次怀孕(p < 0.001)。怀孕的显著预测因素包括:与丧偶或分居相比,年龄较小(风险比[HR] 10.96,95%置信区间[CI] 3.22 - 37.2)、已婚(HR 2.09,95% CI 1.69 - 2.64)和单身(HR 1.95,95% CI 1.34 - 2.84);小学教育程度(HR 1.65,95% CI 1.02 - 2.66);与知道配偶艾滋病毒状况相比,不知道配偶艾滋病毒状况(HR 1.46,95% CI 1.13 - 1.93)。使用计划生育(HR 0.23,95% CI 0.18 - 0.30)以及基线至最近一次计数期间CD4细胞计数增加可预防怀孕。使用抗逆转录病毒治疗不是一个显著的预测因素。
接受常规艾滋病毒护理和治疗的女性的怀孕发生率有所增加,几乎与普通人群相当。因此,常规艾滋病毒护理应纳入这些女性的生殖健康需求。